MedPath

Observational Study to Assess Genotypes/Phenotypes Correlations in Type-2 Diabetic Retinopathy

Completed
Conditions
Type-2 Diabetic Retinopathy
Registration Number
NCT01228981
Lead Sponsor
Association for Innovation and Biomedical Research on Light and Image
Brief Summary

The purpose of this study is to characterize type 2 diabetic patients with initial alterations of diabetic retinopathy (DR) based on 3 different phenotypes previously identified and different patterns of progression in order to correlate this data with genetic information.

Detailed Description

This study aims to to characterize type 2 diabetic patients with initial alterations of diabetic retinopathy (DR) based on three different phenotypes previously identified and different patterns of progression \[Lobo, 2004\] in order to correlate this data with genetic information (based on a list of candidate genes previously identified as being involved in DR).

The results of this study will be used exclusively for scientific purposes.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Type-2 diabetic subjects form the PTDC/SAU-OSM/72635/2006 clinical trial (early stages of non-proliferative retinopathy - level 30 to 35 ETDRS;. females or males; age over 18 years) with a signed Informed Consent for this study.
Exclusion Criteria
  • Cataract or other eye disease that may interfere with fundus examinations; Vitreous syneresis or posterior vitreous detachment; and Dilatation of the pupil < 5 mm.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Phenotypes of Diabetic Retinopathy progression.June 2011
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

AIBILI - Clinical Trials Center

🇵🇹

Coimbra, Portugal

© Copyright 2025. All Rights Reserved by MedPath